Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Organic Chemistry >  Ketones >  1,2,6,7-Tetrahydro-8H-indeno[5,4-b]furan-8-one

1,2,6,7-Tetrahydro-8H-indeno[5,4-b]furan-8-one

Basic information Safety Supplier Related

1,2,6,7-Tetrahydro-8H-indeno[5,4-b]furan-8-one Basic information

Product Name:
1,2,6,7-Tetrahydro-8H-indeno[5,4-b]furan-8-one
Synonyms:
  • 1,2,6,7-Tetrahydro-8H-indeno[5,4-b]furan-8-one
  • 1,2,6,7-Tetrahydro-8H-indeno[5,4-β]furan-8-one
  • RaMelteon I
  • 4-b]furan-8-one
  • 7-tetrahydro-
  • 8H-Indeno[5
  • 1,2,6,7-tetrahydroindeno[5,4-b]furan-8-one
  • Ramelteon Intermediate 1
CAS:
196597-78-1
MF:
C11H10O2
MW:
174.2
EINECS:
1308068-626-2
Product Categories:
  • Heterocycles
  • Aromatics Compounds
  • Aromatics
Mol File:
196597-78-1.mol
More
Less

1,2,6,7-Tetrahydro-8H-indeno[5,4-b]furan-8-one Chemical Properties

Melting point:
149-1510C
Boiling point:
334.2±42.0 °C(Predicted)
Density 
1.288±0.06 g/cm3(Predicted)
storage temp. 
Sealed in dry,Room Temperature
solubility 
Chloroform (Slightly), Ethyl Acetate (Slightly)
form 
Solid
color 
White to Off-White
InChI
InChI=1S/C11H10O2/c12-9-3-1-7-2-4-10-8(11(7)9)5-6-13-10/h2,4H,1,3,5-6H2
InChIKey
ZZUIZMWFNOKNLN-UHFFFAOYSA-N
SMILES
O1CCC2=C3C(CCC3=O)=CC=C12
CAS DataBase Reference
196597-78-1(CAS DataBase Reference)
More
Less

Safety Information

HS Code 
2932.99.7000
HazardClass 
IRRITANT
More
Less

1,2,6,7-Tetrahydro-8H-indeno[5,4-b]furan-8-one Usage And Synthesis

Chemical Properties

White Solid

Uses

A tricyclic indan derivative as receptor agonist; a therapeutic agent for sleep disorders.

Synthesis

196597-77-0

196597-78-1

4,5-Dibromo-1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-one (280 kg, 843 mol) was used as a raw material, mixed with anhydrous sodium acetate (173 kg, 2109 mol) and methanol (6384 L). After the reaction system was replaced with nitrogen, 10% Pd/C catalyst (30.8 kg, dry weight) was added. Subsequently, the reaction mixture was pressurized to 0.29 to 0.49 MPa under a hydrogen atmosphere and catalytically reduced for 8 hours at about 40°C with a stirring rate such that the total gas-liquid mass transfer coefficient, KLa (1/hr), was about 15. Upon completion of the reaction, the catalyst was removed by filtration and the filtrate was concentrated under reduced pressure. Water was added to the concentrated residue, concentrated again under reduced pressure to displace the solvent, cooled and stirred for 1 hour to mature the crystals. The crystallized solution was filtered to give wet 1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-one crystals (dry weight 127 kg, yield 86.6%). The amount of dimer in the wet crystals was less than 0.1 wt%.

References

[1] Journal of Medicinal Chemistry, 2002, vol. 45, # 19, p. 4222 - 4239
[2] Patent: EP1199304, 2002, A1. Location in patent: Referential example 18
[3] Patent: EP1792899, 2007, A1. Location in patent: Page/Page column 13
[4] Patent: CN103570651, 2016, B. Location in patent: Paragraph 0063; 0064
[5] Patent: US6348485, 2002, B1

1,2,6,7-Tetrahydro-8H-indeno[5,4-b]furan-8-oneSupplier

Beijing Whale Technology Corporation Ltd. Gold
Tel
010-83694934 13671295325
Email
sales@whalecorporation.com
Shanghai Haohong Pharmaceutical Co., Ltd. Gold
Tel
400-8210725 400821072
Email
malulu@leyan.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
ZHIWE CHEMTECH CO LTD
Tel
021-20221225 13917446399
Email
zwchem@163.com